Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does DMARD treatment slow or prevent development of RA in patients with UA?

Nature Clinical Practice Rheumatology volume 3, pages 690–691 (2007)Cite this article

boxed-textvan Dongen et al. (2007) Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis. A double-blind, randomized, placebo-controlled trial. Arthritis Rheum 56: 1424–1432

Until undifferentiated arthritis is better defined, we are no further along in our understanding of how best to treat it than we have ever been

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Nielen MM et al. (2004) Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donor. Arthritis Rheum 50: 380–386

    Article  Google Scholar 

  2. Arnett FC et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315–324

    Article  CAS  Google Scholar 

  3. van Gaalen FA et al. (2004) Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 50: 709–715

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Bryony Mearns, Assistant Editor, Nature Clinical Practice.

Author information

Author notes

  1. Albany Medical College, The Center for Rheumatology, 1367 Washington Avenue, Albany, NY 12206, USA jkremer@joint-docs.com

Authors and Affiliations

  1. JM Kremer is a Professor of Medicine at the Center for Rheumatology in Albany, NY, USA.,

    Joel M Kremer

Authors
  1. Joel M Kremer
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kremer, J. Does DMARD treatment slow or prevent development of RA in patients with UA?. Nat Rev Rheumatol 3, 690–691 (2007). https://doi.org/10.1038/ncprheum0628

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0628

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing